Piia manages all collaborative projects encompassing cell therapy development, GMP translation and manufacture of cell therapies for pre-clinical and clinical development.
She has a PhD degree in biomedical technology from University of Tartu and has studied the interplay of viral and host factors in papillomavirus life cycle.
Piia has extensive knowledge of molecular and cell biology.
Piia Kivipõld, PhD
Virol J. 2015 Jul 7;12:104. doi: 10.1186/s12985-015-0335-z.
Piirsoo A, Kasak L, Kauts ML, Loog M, Tints K, Uusen P, Neuman T, Piirsoo M. Protein kinase inhibitor SU6668 attenuates positive regulation of Gli proteins in cancer and multipotent progenitor cells. Biochim Biophys Acta. 2014 Apr;1843(4):703-14.
Kurg R, Uusen P, Võsa L, Ustav M. Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome. Virology. 2010 Dec 20;408(2):159-66.
Kurg R, Uusen P, Sepp T, Sepp M, Abroi A, Ustav M. Bovine papillomavirus type 1 E2 protein heterodimer is functional in papillomavirus DNA replication in vivo. Virology. 2009 Apr 10;386(2):353-9.
Saarinen A, Välimäki VV, Välimäki MJ, Löyttyniemi E, Auro K, Uusen P, Kuris M, Lehesjoki AE, Mäkitie O. The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men. Bone. 2007 Apr;40(4):1006-12.